Germany’s BioNTech SE – ADR (NASDAQ:BNTX) and China’s Shanghai Fosun Pharmaceutical...
Coronavirus was first reported in China in Wuhan city. It came with several pneumonia cases. The virus has quickly become a global pandemic claiming...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) Will Support a New Drug Application (NDA)...
Dry eyes come with discomfort and pain. It can be irritating, and statistics show that more than 15 million detected cases of dry eye...
MAKE IT MODERN
LATEST REVIEWS
Xeris Biopharma Holdings Inc. (NASDAQ: XERS) Reports Net Loss of $26...
Xeris Biopharma Holdings Inc. (NASDAQ: XERS) has announced its financial results for Q3 and nine months ending September 30, 2021, and recent updates, including...
MAKE IT MODERN
PERFORMANCE TRAINING
Aligos Therapeutics ($ALGS): A Bold Move to Regain Nasdaq Compliance
Aligos Therapeutics, Inc. (ALGS), a clinical-stage biopharmaceutical company focusing on liver and viral diseases, recently executed a 1-for-25 reverse stock split. This...
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) CEO Presents Update On Mino-Lok Study At Life Sciences Investors...
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) has announced that its CEO Myron Holubiak will offer a virtual presentation at the Life Sciences Investors Forum, including an...
Omeros Corporation (NASDAQ:OMER) Announce Separate ASC Payment For OMIDRIA® Under CMS Policy
Omeros Corporation (NASDAQ:OMER) has announced the confirmation of a separate ambulatory surgery center payment by the Centres for Medicare & Medicaid Services (CMS) for...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Receives FDA Minutes On Pre-IND meeting For TNX-102...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has received the official minutes of the Type B Pre-Investigational New Drug Application meeting with the FDA to...
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Meets Its Primary and Secondary Endpoint in the Study...
Tarsus Pharmaceuticals Inc's (NASDAQ: TARS) treatment, TP-03, has met primary and secondary endpoints in the company’s Phase III study. The company also found that...
MAKE IT MODERN
